Literature DB >> 21161239

[Treatment of traumatic choroidal neovascularization with ranibizumab].

P Janknecht1.   

Abstract

We report on a patient who had a choroidal rupture after contusion of the eyeball. Some months later choroidal neovascularization appeared which could be treated with ranibizumab. Although the patient was young several injections were necessary before the choroidal neovascularization vanished.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21161239     DOI： 10.1007/s00347-010-2271-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  7 in total

1.  Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture.

Authors:  Christine Shortsleeve Ament; David N Zacks; Anne Marie Lane; Magdalena Krzystolik; Donald J D'Amico; Shizuo Mukai; Lucy H Young; John Loewenstein; Jorge Arroyo; Joan W Miller
Journal:  Arch Ophthalmol       Date:  2006-07

Review 2.  [Blunt ocular trauma. Part II. Blunt posterior segment trauma].

Authors:  A Viestenz; M Küchle
Journal:  Ophthalmologe       Date:  2005-01       Impact factor: 1.059

3.  Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.

Authors:  Ozgur Artunay; Rifat Rasier; Erdal Yuzbasioglu; Alper Sengül; Halil Bahcecioglu
Journal:  Int Ophthalmol       Date:  2008-09-30       Impact factor: 2.031

4.  Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture.

Authors:  Feng Liang; Nathalie Puche; Gisèle Soubrane; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-26       Impact factor: 3.117

5.  Subfoveal neovascular membrane removal in patients with traumatic choroidal rupture.

Authors:  J G Gross; L P King; E de Juan; T Powers
Journal:  Ophthalmology       Date:  1996-04       Impact factor: 12.079

6.  Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator.

Authors:  Mehmet Cakir; Osman Cekiç; Omer F Yilmaz
Journal:  Eur J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.922

7.  Combination of photodynamic therapy with intravitreal bevacizumab for post-peribulbar anesthesia (penetrating trauma)-persistent choroidal neovascular membrane.

Authors:  Nikunj Shah; Urmi Shah
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.